Enveric Biosciences (NASDAQ:ENVB) just reported results for the second quarter of 2024.
- Enveric Biosciences reported earnings per share of -23 cents. This was above the analyst estimate for EPS of -55 cents.
- The company did not report any revenue for the quarter.